Prostate-specific antigen (PSA) is a protein secreted only by epithelial prostate cells, and its elevation in serum is used to detect prostate cancer in men.Elevated PSA levels are associated with prostatitis, inflammation of the prostate or benign forms of prostatic hyperplasia, making it a valuable tumor marker for prostate cancer.The use of serology-based biomarkers for the diagnosis of prostate cancer has stimulated the need for prostate-specific antigen (PSA).

Market Analysis and Insights: Global Prostate-specific Antigen (PSA) Testing Market
The global Prostate-specific Antigen (PSA) Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate-specific Antigen (PSA) Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate-specific Antigen (PSA) Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate-specific Antigen (PSA) Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate-specific Antigen (PSA) Testing market.

Global Prostate-specific Antigen (PSA) Testing Scope and Market Size
Prostate-specific Antigen (PSA) Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostate-specific Antigen (PSA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CLIA Method
ELISA Method

Segment by Application
Screening
Post-treatment Monitoring
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA